These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 10980840

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Direct thrombin inhibition and thrombolytic therapy: rationale for the Hirulog and Early Reperfusion/Occlusion (HERO-2) trial.
    White HD.
    Am J Cardiol; 1998 Oct 22; 82(8B):57P-62P. PubMed ID: 9809893
    [Abstract] [Full Text] [Related]

  • 3. Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators.
    White HD, Aylward PE, Frey MJ, Adgey AA, Nair R, Hillis WS, Shalev Y, Brown MA, French JK, Collins R, Maraganore J, Adelman B.
    Circulation; 1997 Oct 07; 96(7):2155-61. PubMed ID: 9337184
    [Abstract] [Full Text] [Related]

  • 4. Hirudin (desirudin) and Hirulog (bivalirudin) in acute ischaemic syndromes and the rationale for the Hirulog/Early Reperfusion Occlusion (HERO-2) Study.
    White HD, Ellis CJ, French JK, Aylward P.
    Aust N Z J Med; 1998 Aug 07; 28(4):551-4. PubMed ID: 9777138
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A pilot, early angiographic patency study using a direct thrombin inhibitor as adjunctive therapy to streptokinase in acute myocardial infarction.
    Lidón RM, Théroux P, Lespérance J, Adelman B, Bonan R, Duval D, Lévesque J.
    Circulation; 1994 Apr 07; 89(4):1567-72. PubMed ID: 8149522
    [Abstract] [Full Text] [Related]

  • 9. Hirudin and Hirulog.
    White H.
    Aust N Z J Med; 1993 Dec 07; 23(6):769-70. PubMed ID: 8141724
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Direct thrombin inhibition superior to heparin during and after thrombolysis: dose, duration, and drug.
    Chesebro JH.
    Circulation; 1997 Oct 07; 96(7):2118-20. PubMed ID: 9337177
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Failed thrombolysis in myocardial infarction.
    Qasim A, Chauhan A, More RS.
    Int J Cardiol; 2000 Aug 07; 75(1):5-14. PubMed ID: 11054500
    [Abstract] [Full Text] [Related]

  • 17. Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data.
    Direct Thrombin Inhibitor Trialists' Collaborative Group.
    Lancet; 2002 Jan 26; 359(9303):294-302. PubMed ID: 11830196
    [Abstract] [Full Text] [Related]

  • 18. Direct thrombin inhibitors for non-ST-segment elevation acute coronary syndromes: what, when, and where?
    Lincoff AM.
    Am Heart J; 2003 Oct 26; 146(4 Suppl):S23-30. PubMed ID: 14564303
    [Abstract] [Full Text] [Related]

  • 19. Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial.
    Antman EM.
    Circulation; 1996 Sep 01; 94(5):911-21. PubMed ID: 8790025
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.